Diabetes – SGLT2 Inhibitor and WangbangThis is at the licencing stage. My guess is PRC is working this deal as well and the milestone for this is at the very last step according to sirona website.
I suspect the next shoe to drop is PRC and Wangbang. I doubt Howie has anything near term to brag about.